WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹60 Cr | ₹1,072 Cr | ₹934 Cr | ₹889 Cr | ₹1,012 Cr |
What is the latest Contingent Liabilities ratio of WANBURY ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹60 Cr |
Mar2023 | ₹1,072 Cr |
Mar2022 | ₹934 Cr |
Mar2021 | ₹889 Cr |
Mar2020 | ₹1,012 Cr |
How is Contingent Liabilities of WANBURY Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹60 Cr | -94.40 | |
Mar2023 | ₹1,072 Cr | 14.78 | |
Mar2022 | ₹934 Cr | 5.01 | |
Mar2021 | ₹889 Cr | -12.14 | |
Mar2020 | ₹1,012 Cr | - |
Compare Contingent Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹872.5 Cr | 0.8% | -10.7% | -8.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹381,686.0 Cr | -2.5% | -0.2% | -15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,241.0 Cr | -5.9% | -6.9% | 5.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,339.0 Cr | -1.9% | 0.7% | 3.9% | Stock Analytics | |
CIPLA | ₹120,240.0 Cr | -2.6% | -6.4% | -8.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,091.0 Cr | -5.6% | -2.2% | -6.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 0.8% |
-10.7% |
-8.2% |
SENSEX | -2.2% |
0.4% |
-5.4% |
You may also like the below Video Courses